Symbol
BioAtla, Inc.
Full name of the company.
MEDICAL-BIOMED/GENETICS
Industry name
DRUGS
Major industry name
Medical
Sector name
$0.28
Current price of the stock
$892K
Trading volume of the stock
$13.5M
Market capitalization of the company
Nano Cap
Category of market capitalization
-
Long-term growth mean estimate
4.50
Mean analyst rating
2873.95%
Potential price appreciation based on analyst price targets
-
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
-
Total debt to total equity ratio
3.11
Current ratio
100.00%
Gross profit margin
-102.45%
Operating profit margin
-102.45%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-96.24%
Pretax profit margin
-96.24%
Net profit margin
-46.09%
Measures profitability relative to shareholders' equity
-46.09%
ROE excluding intangible assets
-17.01%
Measures profitability relative to total assets
-46.09%
Measures profitability relative to invested capital
0.18
Asset turnover ratio
-
Inventory turnover ratio
-
Receivables turnover ratio
-
Average number of days it takes to collect receivables
-0.17
Measures valuation relative to earnings
-
P/E based on future earnings estimates
1.23
Measures valuation relative to sales
0.59
Measures valuation relative to book value
-0.06
Measures valuation relative to operating cash flow
-0.06
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
